Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Acumen Pharmaceuticals Inc (ABOS)

Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 219,292
  • Shares Outstanding, K 60,080
  • Annual Sales, $ 0 K
  • Annual Income, $ -52,370 K
  • 60-Month Beta 0.19
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.86
Trade ABOS with:

Options Overview Details

View History
  • Implied Volatility 73.69% ( -58.96%)
  • Historical Volatility 60.06%
  • IV Percentile 9%
  • IV Rank 14.06%
  • IV High 336.46% on 11/09/23
  • IV Low 30.69% on 02/12/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 835
  • Put/Call OI Ratio 4.81
  • Today's Open Interest 21,559
  • Open Int (30-Day) 17,299

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.25
  • Number of Estimates 1
  • High Estimate -0.25
  • Low Estimate -0.25
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +10.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.07 +18.89%
on 04/25/24
3.92 -6.89%
on 05/15/24
+0.18 (+5.19%)
since 04/17/24
3-Month
3.07 +18.89%
on 04/25/24
5.09 -28.29%
on 03/04/24
+0.37 (+11.28%)
since 02/16/24
52-Week
1.81 +101.65%
on 11/10/23
11.31 -67.73%
on 07/17/23
-1.80 (-33.03%)
since 05/17/23

Most Recent Stories

More News
2 Penny Stocks That Wall Street Predicts Will Soar Over 300%

While these two penny stocks have the potential for exceptional returns, they also carry greater risk and volatility.

ELDN : 3.02 (+7.86%)
ABOS : 3.65 (-2.14%)
MRNA : 132.90 (+0.17%)
$SPX : 5,303.27 (+0.12%)
MarketBeat Week in Review – 7/17 - 7/21

Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks

U : 21.67 (-1.90%)
MSFT : 420.21 (-0.19%)
META : 471.91 (-0.28%)
GOOGL : 176.06 (+1.08%)
NVDA : 924.79 (-1.99%)
RXRX : 9.42 (-0.95%)
OPK : 1.3200 (+1.54%)
PFE : 28.64 (-0.97%)
TSLA : 177.46 (+1.50%)
AAPL : 189.87 (+0.02%)
GP : 1.3400 (-2.19%)
JNJ : 154.64 (+0.23%)
Acumen Soars on Alzheimer's Study...Street Sees It Doubling

Will the $11.00 level be a double-top ceiling…or can Acumen Pharmaceuticals build momentum and climb towards its $25.00 IPO price?

ABOS : 3.65 (-2.14%)
LLY : 770.00 (-0.15%)
BIIB : 230.57 (+0.23%)
Why Shares of Acumen Pharmaceuticals Are Down Tuesday

The company announced a $100 million stock sale.

ABOS : 3.65 (-2.14%)
Stock Index Futures Muted Ahead of Key U.S. Retail Sales Data, U.S. Bank Earnings on Tap

September S&P 500 futures (ESU23) are down -0.03%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.10% this morning as market participants braced for the next round of quarterly reports while...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
TSLA : 177.46 (+1.50%)
AAPL : 189.87 (+0.02%)
ATVI : 94.42 (-0.05%)
MSFT : 420.21 (-0.19%)
F : 12.28 (-0.81%)
T : 17.40 (+0.58%)
BAC : 39.29 (+0.18%)
MS : 100.22 (+0.64%)
PLD : 111.50 (+0.64%)
LMT : 466.20 (+0.29%)
Is Novo Nordisk (NVO) Stock Outpacing Its Medical Peers This Year?

Here is how Novo Nordisk (NVO) and Acumen Pharmaceuticals, Inc. (ABOS) have performed compared to their sector so far this year.

NVO : 131.89 (-0.86%)
ABOS : 3.65 (-2.14%)
Acumen Pharmaceuticals, Inc. (ABOS) Q2 2022 Earnings Call Transcript

ABOS earnings call for the period ending June 30, 2022.

ABOS : 3.65 (-2.14%)
Acumen Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 15, 2022

CHARLOTTESVILLE, Va. and CARMEL, Ind., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage biopharmaceutical...

ABOS : 3.65 (-2.14%)
Acumen presents poster describing method to standardize amyloid beta oligomer assays supporting therapeutic development for early Alzheimer’s disease

Model designed to fill need for soluble amyloid beta oligomer reference standards in bioanalytical assays...

ABOS : 3.65 (-2.14%)
Acumen Pharmaceuticals to Participate in Upcoming Investor and Scientific Conferences

CHARLOTTESVILLE, Va. and CARMEL, Ind., July 26, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage biopharmaceutical...

ABOS : 3.65 (-2.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Acumen Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It involved in developing a novel disease for Alzheimer. The company's product pipeline consist ACU193. Acumen Pharmaceuticals Inc. is based in CHARLOTTESVILLE, Va.

See More

Key Turning Points

3rd Resistance Point 3.96
2nd Resistance Point 3.87
1st Resistance Point 3.76
Last Price 3.65
1st Support Level 3.55
2nd Support Level 3.45
3rd Support Level 3.34

See More

52-Week High 11.31
Fibonacci 61.8% 7.68
Fibonacci 50% 6.56
Fibonacci 38.2% 5.44
Last Price 3.65
52-Week Low 1.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar